Investors

INMODE INVESTOR PORTAL

CORPORATE OVERVIEW


InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

COMPANY HIGHLIGHTS

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode to Present at Upcoming Investor Conferences

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Financials & Filings

SEC FILINGS

Contact Us

Contact Us